SH2B3 (LNK) rs3184504 polymorphism is correlated with JAK2 V617F-positive myeloproliferative neoplasms
Authors:
Adrian P. Trifa, Diana L. Lighezan, Cristina Jucan, Florin Tripon, Dana R. Arbore, Anca Bojan, Ștefana Gligor-Popa, Raluca M. Pop, Delia Dima, Claudia Bănescu
2
Prognostic value of immunohistochemical expression of ZAP-70 and CD38 in chronic lymphocytic leukaemia detected on bone marrow and lymph node biopsies
Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
Authors:
Delia Dima, Adrian P. Trifa, Mariana Pațiu, Cristian S. Vesa, Ioana C. Frinc, Ljubomir Petrov, Andrei Cucuianu
5
Long term remission after treatment with Rituximab in a case of thrombotic thrombocythopenic purpura
Authors:
Delia Dima, Ioana Codruța Frinc, Mariana Pațiu, Andrei Cucuianu
6
Monitoring T315I mutation in chronic myeloid leukemia by amplification refractory mutation system PCR
Authors:
Delia Dima, Adrian P Trifa, Andrei Cucuianu, Radu A Popp, Mariana Paţiu, Ljubomir Petrov
7
Multiparametric approach of prognostic factors in acute myeloid leukemia – a bicentric study
Authors:
Anca Bacârea, Mariana Paţiu, Andrei Cucuianu, Delia Dima, Vladimir Bacârea, Bogdana Dorcioman, Minodora Dobreanu, Galafteon Oltean
8
JAK2 p.V617F mutation – tetra-primer PCR and PCR-RFLP comparative semiquantitative approaches for estimation of the mutant allele in myeloproliferative neoplasms
Authors:
Adrian P. Trifa, Radu A. Popp, Andrei Cucuianu, Delia Dima, Mariela S. Militaru, Mariana Paţiu, Ioan V. Pop
